Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 35851 - 35875 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Doxorubicin	Approved Investigational	CASP1	834	upregulated	Doxorubicin results in increased expression of CASP1 mRNA	11q22.3	A21894
Doxorubicin	Approved Investigational	CASP10	843	upregulated	Doxorubicin results in increased expression of CASP10 mRNA	2q33.1	A21894
Doxorubicin	Approved Investigational	CASP2	835	upregulated	Doxorubicin results in increased expression of CASP2 mRNA alternative form	7q34	A20664
Doxorubicin	Approved Investigational	CASP3	836	upregulated	Doxorubicin results in increased expression of CASP3 mRNA	4q35.1	A22194 A22427 A21894 A22441
Doxorubicin	Approved Investigational	CASP6	839	upregulated	Doxorubicin results in increased expression of CASP6 mRNA	4q25	A21894
Doxorubicin	Approved Investigational	CASP7	840	upregulated	Doxorubicin results in increased expression of CASP7 mRNA	10q25.3	A21894 A22441
Doxorubicin	Approved Investigational	CASP8	841	upregulated	Doxorubicin results in increased expression of CASP8 mRNA	2q33.1	A21894
Doxorubicin	Approved Investigational	CASP9	842	downregulated	Doxorubicin results in decreased expression of CASP9 mRNA	1p36.21	A22196
Doxorubicin	Approved Investigational	CASP9	842	upregulated	Doxorubicin results in increased expression of CASP9 mRNA	1p36.21	A22194 A22427 A21894 A22435
Doxorubicin	Approved Investigational	CCNA2	890	downregulated	Doxorubicin results in decreased expression of CCNA2 mRNA	4q27	A22430
Doxorubicin	Approved Investigational	CCNB1	891	downregulated	Doxorubicin results in decreased expression of CCNB1 mRNA	5q13.2	A22430
Doxorubicin	Approved Investigational	CCNE1	898	upregulated	Doxorubicin results in increased expression of CCNE1 mRNA	19q12	A22450
Doxorubicin	Approved Investigational	CD44	960	upregulated	Doxorubicin results in increased expression of CD44 mRNA	11p13	A22441
Doxorubicin	Approved Investigational	CDK1	983	downregulated	Doxorubicin results in decreased expression of CDK1 mRNA	10q21.2	A22430
Doxorubicin	Approved Investigational	CDK10	8558	upregulated	Doxorubicin results in increased expression of CDK10 mRNA	16q24.3	A22426
Doxorubicin	Approved Investigational	CDKN1A	1026	upregulated	Doxorubicin results in increased expression of CDKN1A mRNA	6p21.2	A22430 A22437 A22441 A22451 A22452 A22433 A22431 A22435
Doxorubicin	Approved Investigational	CDKN2A	1029	upregulated	Doxorubicin results in increased expression of CDKN2A mRNA	9p21.3	A22441
Doxorubicin	Approved Investigational	CEBPB	1051	upregulated	Doxorubicin results in increased expression of CEBPB mRNA	20q13.13	A21894
Doxorubicin	Approved Investigational	CES2	8824	upregulated	Doxorubicin results in increased expression of CES2 mRNA	16q22.1	A22430
Doxorubicin	Approved Investigational	CHEK1	1111	downregulated	Doxorubicin results in decreased expression of CHEK1 mRNA	11q24.2	A22453
Doxorubicin	Approved Investigational	CHI3L1	1116	upregulated	Doxorubicin results in increased expression of CHI3L1 mRNA	1q32.1	A22430
Doxorubicin	Approved Investigational	CKM	1158	downregulated	Doxorubicin results in decreased expression of CKM mRNA	19q13.32	A21904
Doxorubicin	Approved Investigational	CLDN1	9076	downregulated	Doxorubicin results in decreased expression of CLDN1 mRNA	3q28	A22426
Doxorubicin	Approved Investigational	CLIP1	6249	upregulated	Doxorubicin results in increased expression of CLIP1 mRNA	12q24.31	A22426
Doxorubicin	Approved Investigational	CLU	1191	upregulated	Doxorubicin results in increased expression of CLU mRNA	8p21.1	A22431

Displaying entries 35851 - 35875 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability